Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria

Scandinavian Journal of Urology and Nephrology

Volumn 45, Issue 1, 2011, Pages 52-59

  Wasilewska, Anna ^a   Zoch Zwierz, Walentyna ^a   Taranta Janusz, Katarzyna ^a   Kołodziejczyk, Zbigniew ^a  

^a UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Monocyte chemoattractant protein 1; nephrotic syndrome; proteinuria

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE; STEROID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; SCHOOL CHILD; STEROID THERAPY; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CREATININE; CYCLOSPORINE; FEMALE; GLOMERULONEPHRITIS, IGA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY GLOMERULUS; MALE; NEPHROTIC SYNDROME; PROTEINURIA; SEVERITY OF ILLNESS INDEX;

EID: 79951627755     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2010.526140     Document Type: Article

References (44)

1. Zoja C, Abbate M, Remuzzi G. Progression of chronic kidney disease: insights from animal models. Curr Opin Nephrol Hypertens 2006;15:250-7.
2. Palmer BF. Proteinuria as a therapeutic target in patients with chronic kidney disease. Am J Nephrol 2007;27:287-93. (Pubitemid 47177217)
3. Viedt C, Orth SR. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant 2002;17:2043-7. (Pubitemid 35446657)
4. Yoshimura T, Leonard EJ. Human monocyte chemoattractant protein-1: structure and function (review). Cytokines. 1992;4:131-52.
5. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 2000;58:684-90. (Pubitemid 30620017)
6. Prodjosudjadi W, Gerritsma JS, van Es LA, Daha MR, Bruijn JA. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 1995;44:148-55.
7. Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 1996;27:640-6. (Pubitemid 26135835)
8. Cockwell P, Howie AJ, Adu D, Savage CO. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int 1998;54:827-36. (Pubitemid 28397400)
9. Mezzano SA, Droguett MA, Burgos ME, Ardiles LG, Aros CA, Caorsi I, et al. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 2000;57:147-58. (Pubitemid 30227762)
10. Wang Y, Rangan GK, Tay YC, Wang Y, Harris DC. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 1999;10:1204-13. (Pubitemid 29246985)
11. Qi W, Chen X, Polhill TS, Sumual S, Twigg S, Gilbert RE, et al. TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol 2006;290: F703-9. (Pubitemid 43724973)
12. Wang SN, Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am J Physiol Renal Physiol 2000;278: F554-60. (Pubitemid 30215232)
13. Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, et al. Urinary levels of epidermal growth factor. Interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton) 2009;14:613-20.
14. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000;58:1492-9.
15. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 2004;19:2505-12. (Pubitemid 39360096)
16. Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diabetes Complications 2003;17:11-5. (Pubitemid 36042786)
17. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003;362:629-39. (Pubitemid 37013306)
18. Souto MF, Teixeira AL, Russo RC, Penido MG, Silveira KD, Teixeira MM, et al. Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria. Pediatr Res 2008;64:637-42.
19. Schlöndorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int 1997;51:610-21. (Pubitemid 27157943)
20. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, et al. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 1995;73:804-9. (Pubitemid 26002339)
21. Jin KB, Choi HJ, Kim HT, Hwang EA, Han SY, Park SB, et al. Cytokine array after cyclosporine treatment in rats. Transplant Proc 2008;40:2682-4.
22. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007;71:1205-14. (Pubitemid 46884251)
23. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008;172:299-308. (Pubitemid 351282018)
24. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006;69:2131-47. (Pubitemid 43882099)
25. Huang Z, Wen Q, Zhou SF, Yu XQ. Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome. Cytokine 2008;42:222-33.
26. Shimizu H, Maruyama S, Yuzawa Y, Kato T, Miki Y, Suzuki S, et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol 2003;14:1496-505. (Pubitemid 36687051)
27. Remuzzi G. A unifying hypothesis for renal scarring linking protein trafficking to the different mediators of injury. Nephrol Dial Transplant 2000;15(Suppl 6): 58):58-60.
28. Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, et al. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases. Ren Fail 2003;25:439-44. (Pubitemid 36666464)
29. Rovin BH, Yoshiumura T, Tan L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 1992;148:2148-53.
30. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 1994;71:536-42. (Pubitemid 24338161)
31. Ou ZL, Hotta O, Natori Y, Sugai H, Taguma Y, Natori Y. Enhanced expression of C chemokine lymphotactin in IgA nephropathy. Nephron 2002;91:262-9. (Pubitemid 34621693)
32. Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, Kobayashi K, et al. Urinary levels of chemokines (MCAF/MCP-1. IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukoc Biol 1998;63:493-9. (Pubitemid 28163190)
33. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, Marra F, et al. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 1996;7:906-13. (Pubitemid 27465985)
34. Sun Y, Yuan S, Xu X. Expression of MCP-1 in renal tissues of patients with IgA nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34:1023-8.
35. Sean Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005;68:437-55. (Pubitemid 43323099)
36. Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W, et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol 2002;22:914-20. (Pubitemid 34655217)
37. Viedt C, Dechend R, Fei J, Hänsch GM, Kreuzer J, Orth SR. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors. nuclear factor-kappaB and activating protein-1. J Am Soc Nephrol 2002;13:1534-47. (Pubitemid 34579243)
38. Suda T, Osajima A, Tamura M, Kato H, Iwamoto M, Ota T, et al. Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase. Kidney Int 2001;60:1705-15. (Pubitemid 32999975)
39. Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, et al. Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 2000;36:1226-41.
40. Hilgers KF, Hartner A, Porst M, Mai M, Wittmann M, Hugo C, et al. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 2000;58:2408-19.
41. Wada T, Yokoyama H, Su SB, Mukaida N, Iwano M, Dohi K, et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996;49:761-7. (Pubitemid 26093085)
42. Stephan M, Conrad S, Eggert T, Heuer R, Fernandez S, Huland H. Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction. J Urol 2002;167:1497-502. (Pubitemid 34132139)
43. Wang QY, Chen FQ. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Diabetes Res Clin Pract 2008;83:215-9.
44. Alzawawy A, Zohary M, Ablordiny M, and Eldalie M. Estimation of monocyte-chemoattractant protein-1 (MCP-1) level in patients with lupus nephritis. Int J Rheum Dis 2009;12:311-8.